Sangamo Therapeutics Launches Auction Process for Clinical-Stage Chronic Neuropathic Pain Program 13 October
Sangamo Therapeutics Selects Successful Bidders Following Competitive Asset Auction for $163.55 Million in Cash Consideration at Closing and Up to $100 Million in Potential Milestones 12 August
